Top Markets
Coin of the day
Shandong Sito Bio-technology Co., Ltd. Shandong Sito Bio-technology Co., Ltd.

Shandong Sito Bio-technology Co., Ltd.

300583
Rank in Stocks #14488
Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces... Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, ethylene deltenone, 16ß and 16a methyl epoxide, and hexahydro-3a-methyl, as well as androsta-1,4-diene-3,17-dione and estra-4,9-diene-3,17-dione. Shandong Sito Bio-technology Co., Ltd. was founded in 2002 and is based in Heze, China.
Share Price
$2.17
Market Cap
$411.81M
Change (1 day)
1.84%
Change (1 year)
-6.47%
Country
CN
Trade Shandong Sito Bio-technology Co., Ltd. (300583)

Category

Operating Margin for Shandong Sito Bio-technology Co., Ltd. (300583)
Operating Margin as of 2026 TTM: 0.00%
According to Shandong Sito Bio-technology Co., Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Shandong Sito Bio-technology Co., Ltd. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
62.34% -
US
0.00% -
SE
0.00% -
FR
0.00% -
IT
0.77% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.